Arteos II Study: Relationship Between Osteoporosis and Arterial Rigidity Within Fractured Patients Cohort
- Conditions
- Osteoporosis
- Registration Number
- NCT01587456
- Lead Sponsor
- Central Hospital, Nancy, France
- Brief Summary
The investigators planned to study relationship between osteoporosis and arterial rigidity within fractured patients cohort.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
- women and men > 60 years of age
- medical history of low energy fracture
- DXA Tscore -2,5 DS
- FREE AND INFORMED CONSENT SIGNED
Exclusion Criteria
- women and men < 60 years of age
- Corticoids treatment
- Breast cancer or prostat cancer medical history
- High energy fracture (traumatic fracture)
- No social security affiliation
- Incapacity to informed consent signed.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link osteoporosis with arterial rigidity in fracture patients as studied in NCT01587456?
How does arterial rigidity in osteoporotic fracture patients compare to standard cardiovascular risk factors in predicting outcomes?
Are there specific biomarkers that correlate with both osteoporosis severity and arterial stiffness in NCT01587456 participants?
What adverse events are associated with arterial rigidity measurements in osteoporosis patients undergoing fracture evaluation?
How might findings from NCT01587456 influence combination therapies targeting both bone density and vascular health in elderly populations?
Trial Locations
- Locations (1)
CHU de Brabois Endocrinology
🇫🇷Vandoeuvre, France